Quick Answer
Organon & Co. reported Long Term Debt of $8.63 billion for the year ending 2025.
- Organon & Co. showed a decrease of -2.6% in Long Term Debt from 2024 to 2025.
- This data is from Organon & Co.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $9.31 billion | Q3 2021: $9.26 billion | Q1 2022: $9.09 billion | Q2 2022: $8.88 billion | Q3 2022: $8.69 billion | Q1 2023: $8.70 billion | Q2 2023: $8.72 billion | Q3 2023: $8.65 billion | Q1 2024: $8.71 billion | Q2 2024: $8.65 billion | Q3 2024: $8.74 billion | Q1 2025: $8.94 billion | Q2 2025: $8.78 billion | Q3 2025: $8.78 billion.
- Historical annual values: Fiscal year 2025: $8.63 billion | Fiscal year 2024: $8.86 billion | Fiscal year 2023: $8.75 billion | Fiscal year 2022: $8.91 billion | Fiscal year 2021: $9.13 billion | Fiscal year 2020: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: